Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment

2003-11-01

European Journal of Endocrinology , Volume 149 - Issue 5 p. 443- 447

Additional Metadata
Persistent URL	doi.org/10.1530/eje.0.1490443, hdl.handle.net/1765/56033
Journal	European Journal of Endocrinology
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Weetman, A., Shepherdley, C., Mansell, P., Ubhi, C., & Visser, T. (2003). Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. European Journal of Endocrinology, 149(5), 443–447. doi:10.1530/eje.0.1490443

Publication